IN2013MU01241A - - Google Patents

Info

Publication number
IN2013MU01241A
IN2013MU01241A IN1241MU2013A IN2013MU01241A IN 2013MU01241 A IN2013MU01241 A IN 2013MU01241A IN 1241MU2013 A IN1241MU2013 A IN 1241MU2013A IN 2013MU01241 A IN2013MU01241 A IN 2013MU01241A
Authority
IN
India
Prior art keywords
methylphenidate
salts
release
pharmaceutical compositions
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Rahul Sudhakar Dabre
Jitendrakumar Chordiya
Inderjeetsingh Huda
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/060084 priority Critical patent/WO2014174388A1/fr
Priority to IN1241MU2013 priority patent/IN2013MU01241A/en
Publication of IN2013MU01241A publication Critical patent/IN2013MU01241A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1241MU2013 2013-03-29 2014-03-24 IN2013MU01241A (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/060084 WO2014174388A1 (fr) 2013-03-29 2014-03-24 Compositions pharmaceutiques à libération modifiée de méthylphénidate ou de ses sels
IN1241MU2013 IN2013MU01241A (fr) 2013-03-29 2014-03-24

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1241MU2013 IN2013MU01241A (fr) 2013-03-29 2014-03-24

Publications (1)

Publication Number Publication Date
IN2013MU01241A true IN2013MU01241A (fr) 2015-04-17

Family

ID=54395625

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1241MU2013 IN2013MU01241A (fr) 2013-03-29 2014-03-24

Country Status (1)

Country Link
IN (1) IN2013MU01241A (fr)

Similar Documents

Publication Publication Date Title
PH12019502355A1 (en) Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
MX2013011908A (es) Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
BR112015003188A2 (pt) Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
MX2013012053A (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
PH12015500724A1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
MX2013011691A (es) Inhibidores de la replicacion viral, su proceso de preparacion y sus usos terapeuticos.
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
MX367926B (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
MX2013002118A (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
IN2014DN09437A (fr)
MX2016000037A (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
GB201115977D0 (en) Neurodevelopmental disorders
MX2013002295A (es) 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
IN2013MU01240A (fr)
IN2013MU01242A (fr)
IN2013MU01241A (fr)
IN2013MU01249A (fr)
IN2013MU01248A (fr)
IN2013MU01247A (fr)
IN2013MU01246A (fr)
IN2013MU01250A (fr)
IN2013MU01245A (fr)
IN2013MU01244A (fr)
IN2013MU01239A (fr)